The U.S. Patent and Trademark Office has awarded Cellular Dynamics International patents on the reprogramming of human cells into pluripotent stem cells from human blood, the company announced today. “These…

Cellular Dynamics International announced recently that it will supply the Nestlé Institute of Health Sciences SA (NIHS) with its iCell and MyCell lines for nutritional research. “The ongoing work and this long-term…

Cellular Dynamics International announced today it signed an agreement with the Jain Foundation to create five induced pluripotent stem cell (iPSC) lines from patients with muscular dystrophies for the eventual purpose of drug…

The U.S. Patent and Trademark Office on Monday issued Cellular Dynamics International a patent that relates to the method by which adult tissue cells are reprogrammed into induced pluripotent stem (iPS)…

Cellular Dynamics International‘s initial public offering raised $43 million, after deducting underwriting discounts and commissions, the company announced today. Sales of the stock (ICEL) began on July 25. According to a…

Cellular Dynamics International, Inc., will price its 3,846,000 shares of common stock at $12 per share, the company announced today. The shares will begin trading on Thursday on the Nasdaq Global…

Cellular Dynamics International announced this week that it has filed with the SEC for an initial public offering of common stock. The company founded by stem cell pioneer James Thomson develops…

Cellular Dynamics International announced this week that it received $16 million from  the California Institute for Regenerative Medicine to create three induced pluripotent stem cell (iPSC) lines for each of 3,000 healthy…

GE Healthcare Life Sciences announced today that it will license Cellular Dynamics International (CDI) to develop, manufacture and sell cellular assays and models derived from induced pluripotent stem cells for use…